Gov. DeSantis announces rapid response team to expand use of monoclonal antibody treatments for COVID-19 patients


SURFSIDE, FLORIDA - AUGUST 10: Florida Gov. Ron DeSantis speaks during an event to give out bonuses to first responders held at the Grand Beach Hotel Surfside on August 10, 2021 in Surfside, Florida. DeSantis gave out some of the $1,000 checks that the Florida state budget passed for both first responders and teachers across the state. (Photo by Joe Raedle/Getty Images)

SURFSIDE, FLORIDA – AUGUST 10: Florida Gov. Ron DeSantis speaks during an event to give out bonuses to first responders held at the Grand Beach Hotel Surfside on August 10, 2021 in Surfside, Florida. (Joe Raedle/Getty Images)

OAN Newsroom
UPDATED 11:01 AM PT – Saturday, August 14, 2021

Fla. Gov. Ron DeSantis announced the launch of a rapid response team to expand the use of monoclonal antibody treatments for COVID-19 patients. DeSantis touted the effectiveness of the monoclonal antibody treatment in a press conference on Thursday. He added the procedure was specifically designed for high-risk patients, such as the elderly or immunocompromised.

The antibody procedure can reportedly be used to treat mild to moderate COVID-19 cases in anyone over the age of 12 and can be used on both unvaccinated and vaccinated individuals.

“This is the most effective treatment that we’ve yet encountered for people who are actually infected with COVID-19 and the way it works, I mean, that there’s a core group of people that benefit from this and those are folks that are at the most high risk for severe illness from COVID-19,” said DeSantis.

Florida officials have been looking to expand the use of the treatment amid a surge of COVID-19 cases throughout the Sunshine State, in an effort to relieve pressure on the state’s healthcare systems.

MORE NEWS: Report: More Than 200K Illegal Immigrant Encounters In July





Source link

carleyshaffer1
Author: carleyshaffer1

Be the first to comment

Leave a Reply

Your email address will not be published.


*